We are live on ! Find out more
PCS

Personal CFO Solutions Portfolio holdings

AUM $712M
1-Year Est. Return 25.3%
This Fund
S&P 500
This Quarter Est. Return
+6.19%
1 Year Est. Return
+25.3%
3 Year Est. Return
+74.76%
5 Year Est. Return
+83.43%
10 Year Est. Return
AUM
$534M
AUM Growth
+$46.2M
Cap. Flow
+$23.2M
Cap. Flow %
4.34%
Top 10 Hldgs %
28.65%
Holding
530
New
77
Increased
220
Reduced
162
Closed
54

Sector Composition

Rank Sector Weight
1 Healthcare 11.88%
2 Technology 11.85%
3 Industrials 9.58%
4 Financials 9.54%
5 Communication Services 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALKS icon
451
Alkermes
ALKS
$8.68B
$200K 0.04%
+8,600
New +$226K
HPE icon
452
Hewlett Packard
HPE
$59.5B
$195K 0.04%
12,370
+41
+0.3% +$618
ISEE
453
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$189K 0.04%
11,300
RNAC icon
454
Cartesian Therapeutics
RNAC
$240M
$181K 0.03%
1,846
+401
+28% +$43.1K
CERS icon
455
Cerus
CERS
$639M
$180K 0.03%
26,500
-1,500
-5% -$10.1K
UMC icon
456
United Microelectronic
UMC
$51B
$161K 0.03%
13,777
+102
+0.7% +$1.14K
HIVE
457
HIVE Digital Technologies
HIVE
$818M
$158K 0.03%
12,000
VSTM icon
458
Verastem
VSTM
$508M
$138K 0.03%
5,614
-583
-9% -$18.4K
DSX icon
459
Diana Shipping
DSX
$270M
$130K 0.02%
+41,818
New +$140K
MUFG icon
460
Mitsubishi UFJ Financial
MUFG
$241B
$105K 0.02%
19,216
+3,441
+22% +$19.4K
ADAP
461
DELISTED
Adaptimmune Therapeutics
ADAP
$99K 0.02%
26,388
-10,000
-27% -$45.5K
LYG icon
462
Lloyds Banking Group
LYG
$85.4B
$71K 0.01%
27,746
+8,129
+41% +$20.7K
NGNE icon
463
Neurogene
NGNE
$746M
$56K 0.01%
585
-651
-53% -$79.3K
SAN icon
464
Banco Santander
SAN
$190B
$51K 0.01%
15,551
-6,973
-31% -$24.5K
AVEO
465
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$47K 0.01%
10,000
-13,000
-57% -$80.6K
ABEV icon
466
Ambev
ABEV
$47.6B
$44K 0.01%
15,584
+2,348
+18% +$6.73K
MREO
467
Mereo BioPharma
MREO
$49.6M
$41K 0.01%
25,888
-7,500
-22% -$15K
TLIS
468
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$40K 0.01%
667
-466
-41% -$34.9K
ITUB icon
469
Itaú Unibanco
ITUB
$91.7B
$39K 0.01%
11,924
-12,267
-51% -$44.2K
DBVT
470
DBV Technologies
DBVT
$844M
$26K ﹤0.01%
1,609
ARDX icon
471
Ardelyx
ARDX
$1.26B
$22K ﹤0.01%
20,000
CARM
472
DELISTED
Carisma Therapeutics
CARM
$15K ﹤0.01%
+900
New +$18.1K
CETX icon
473
Cemtrex
CETX
$5.03M
0
TYME
474
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$7K ﹤0.01%
11,000
-500
-4% -$430
EVFM
475
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$6K ﹤0.01%
1,059

Similar funds

Personal CFO Solutions's Q4 2021 Portfolio in Review

As of Q4 2021, Personal CFO Solutions held 530 positions worth $534M, up 9.5% from $488M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Personal CFO Solutions deployed $23.2M of net new capital in Q4 2021, opening 77 new positions and adding to 220 existing holdings. Its largest new stake was Innovator US Equity Power Buffer ETF January: 724,600 shares worth $24.1M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $22.7M trimmed.

  • Personal CFO Solutions's largest Q4 2021 buy was Innovator US Equity Power Buffer ETF January: 724,600 shares worth $24.1M.
  • Personal CFO Solutions added most to iShares MSCI EAFE ETF in Q4 2021, an estimated $21.5M increase.
  • Personal CFO Solutions's biggest Q4 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $22.7M.
  • Personal CFO Solutions fully exited Innovator US Equity Power Buffer ETF September in Q4 2021, selling an estimated $23M.
  • Personal CFO Solutions's ten largest holdings make up 29% of its $534M portfolio in Q4 2021.
  • Personal CFO Solutions opened 77 new positions and closed 54 in Q4 2021.
  • Personal CFO Solutions's portfolio value rose 9.5% quarter-over-quarter to $534M.

Based on Personal CFO Solutions's 13F filing for Q4 2021, filed 11 Feb 2022.